← Open Payments lookup

KELLY DOLLINGER: Open Payments

NPI 1407232978 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,657 in 54 payments from 23 companies in 2025. Trend: 2023 $1,171 · 2024 $1,002 · 2025 $2,657

Food & beverage: $1,299Long term medical supply or device loan: $1,180Education: $178
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation18$1,346
Kite Pharma, Inc.2$251
Astellas Pharma US Inc2$133
Daiichi Sankyo Inc.2$112
Merck Sharp & Dohme LLC4$112
Ipsen Biopharmaceuticals, Inc2$107
Genentech USA, Inc.3$81
GlaxoSmithKline, LLC.3$69
PharmaEssentia USA Corporation2$55
Incyte Corporation2$51

Products named: KISQALI, Yescarta, KEYTRUDA, DATROWAY, SCEMBLIX, BESREMI, Phesgo, BRUKINSA.

Industry payments across SC — which companies pay providers there.